Genetic Counselling for those with a Family History of Breast or Ovarian Cancer: Current Practice and Ethical Issues

REFERENCES

• Morrison PJ. Genetic testing and insurance in the United Kingdom. Clin Genet 1998; 54: 375–9.
   Google Scholar
• Couch FJ, Weber BL. Breast cancer. In: Vogelstein B, Weber BL, eds. The genetic basis of human cancer. New York: McGraw Hill, 1998: 537–65.
   Google Scholar
• Haber DA, Fearon ER. The promise of cancer genetics. Lancet 1998; 351 (Suppl 11): 1–8.
   Google Scholar
• Bishop DT, Kierneney A. Family studies and the evidence for genetic susceptibility to prostrate cancer. Cancer Biol 1997; 8: 45–51.
   PubMed Web of Science ®Google Scholar
• Easton DF, Ford D, Bishop DT. Breast Cancer Linkage Consortium. Breast and ovarian cancer incidence in BRCA1 mutation carriers. Am J Hum Genet 1995; 56: 265–71.
   Google Scholar
• Easton DF, Bishop DT, Ford D, Crockford GP. Breast Cancer Linkage Consortium. Genetic linkage analysis in fa-milial breast and ovarian cancer: results from 214 families. Am J Hum Genet 1993; 52: 678–701.
   Google Scholar
• Wooster R, Neuhausen SL, Mangion J, et al. Localization of a breast cancer susceptibility gene, BRCA2 to chromosome 13q. Science 1994; 265: 2088–90.
   PubMed Web of Science ®Google Scholar
• Whittemore AS, Gonr G, Itnyre J. Prevalence and contribu-tion of BRCA1 mutations in breast cancer and ovarian cancer: results from three US population-based case-control studies of ovarian cancer., Am J. Hum Genet 1997; 60: 496–504.
   Google Scholar
• Thorlacius S, Struewing JP, Hartge P, et al. Population-based study of risk of breast cancer in carriers of BRCA2 mutation. Lancet 1998; 352: 1337–9.
   PubMed Web of Science ®Google Scholar
• Fitzgerald GM, MacDonald DJ, KraMer M, et al. Germline mutations in Jewish and non Jewish women with early-onset breast cancer. N Engl J Med 1996; 334: 143–9.
   PubMed Web of Science ®Google Scholar
• First European Breast Cancer Conference. Florence state-ment. html@ www.cortc.be 1998. pp. 2.
   Google Scholar
• Wilfond BS, Rothenberg EJ, Thomson EJ, et al. for the Cancer Genetic Studies Consortium, National Institute of Health. Cancer genetic susceptibility testing: ethical and pol-icy implications for future research and clinical practice. J Law Med Ethics 1997; 25: 243–51.
   Google Scholar
• Ponder M, Green JM. BRCA1 testing: some issues in moving from research to service. Psychooncology 1996; 5: 223–32.
   Google Scholar
• American Society of Clinical Oncology. Genetic testing for cancer susceptibility. Oncology 1966; 14: 1730–6.
   Google Scholar
• Eeles RA, Murday VA. The cancer family clinic. In: Eeles RA, Ponder BJ, Easton DF, Horwich A, eds. Genetic predis-position to cancer. London: Chapman and Hall Medical, 1996: 356–71.
   Google Scholar
• Foulkes WD. BRCA1 and BRCA2 penetrating the clinical arena. Lancet 1998; 852: 1325–6.
   Google Scholar
• Hallowell N, Statham H, Murton F, et al. Talking about chance: the presentation of risk information during genetic counselling for breast and ovarian cancer. J Genet Counseling 1997; 6: 269–86.
   PubMedGoogle Scholar
• Boltorff. JL, Ratner PA, Johnson JL, Lovato CY, Joab SA. Communicating cancer risk information: the challenges of uncertainty. Patient Education and Counseling 1998; 33: 67–81.
   Google Scholar
• Hallowell N, Green JM, Statham H, et al. Recall of numerical risk estimates and counsellees' perceptions of the importance of risk information following genetic counselling for breast and ovarian cancer. Psychol Health and Med 1997; 2: 149–59.
   Google Scholar
• Hallowell N, Statham H, Murton F. Women's understanding of their risk of developing breast/ovarian cancer before and after their attendance at a cancer genetics clinic. J Genet Counseling 1998; 7: 345–64.
   Google Scholar
• Gallion HH, Park R. Developing intervention/prevention strategies for individuals at high risk of developing hereditary ovarian cancer. Cancer. J Natl Cancer Inst Mongr 1995; 17: 103–6.
   Google Scholar
• Beckman MW, Schnurch HG, Bodden-Heidrich R, et al. Early cancer detection programmes for women at high risk of breast and ovarian cancer: a proposal of practical guidelines. J Cancer Prevention 1996; 5: 468–75.
   Google Scholar
• Ferrini R. Screening asymptomatic women for ovarian can-cer. American College of Preventive Medicine practice policy. Am J Prey Med 1997; 13: 444–6.
   PubMed Web of Science ®Google Scholar
• Burke W, Daly M, Garber J, et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. 2. BRCA1 and BRCA2. J Am Med Assoc 1998; 277: 997–1003.
   Google Scholar
• Tobacman JK, Greene MH, Tucker MA, et al. Intra-abdom-inal carcionomatosis after prophylactic oophorectomy in ovarian-cancer-prone families. Lancet 1982; ii: 195–99.
   Google Scholar
• Ziegler LD, Kroll SS. Primary breast cancer after prophylac-tic mastectomy. Am J Clin Oncol 1991; 14: 451–4.
   Google Scholar
• Piver MS, Jishi MF, Tsukada Y, Nava G. Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the Gilda Radner Familial Ovarian Cancer Registry. Cancer 1993; 71: 2751–5.
   Google Scholar
• Schrag D, Kurtz KM, Garber JE, Weeks JC. Decision analy-sis-effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations. N Engl J Med 1997; 336: 1465–71.
   PubMed Web of Science ®Google Scholar
• Hartmann LC, Schaid DJ, Woods JE, et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 1999; 340: 77–84.
   PubMed Web of Science ®Google Scholar
• Lerman C, Narod S. Schulman K, et al. BRCA1 testing in families with hereditary breast-ovarian cancer. J Am Med Assoc 1996; 275: 1885–92.
   PubMed Web of Science ®Google Scholar
• Serova OM, Mazoyer S, Puget N, et al. Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer susceptibility genes? Am J Hum Genet 1997; 60: 486–95.
   Google Scholar
• Pharoah P, Mackay J, Zimmern R. Managing women at high risk of breast cancer because of a family history. Paper presented at a Consensus Conference. London: January 1998.
   Google Scholar
• Green JM, Richards MPM, Murton F, Statham HE, Hallow-ell N. Family communication and genetic counseling. The case of hereditary breast and ovarian cancer. J Genet Coun-seling 1997; 6: 45–60.
   Google Scholar
• Richards MPM. Families, kinship and genetics. In: Marteau T, Richards MPM, eds. The troubled helix: social and psy-chological implications of the new human genetics. Cam-bridge: Cambridge University Press, 1996: 249–73.
   Google Scholar
• Hopwood P. Psychological issues in cancer genetics, current research and future priorities. Patient Education and Counsel-ing 1997; 32: 19–31.
   PubMed Web of Science ®Google Scholar
• Hallowell N, Murton F, Statham H, Green JM, Richards MPM. Women's need for information before attending ge-netic counselling for familial breast or ovarian cancer: a questionnaire, interview and observational study. Br Med J 1997; 314: 281–3.
   Google Scholar
• Audrain J, Rimer B, Cella D, et al. Genetic counseling and testing for breast-ovarian cancer susceptibility: what do women want? J Clin Oncol 1998; 16: 133–8.
   PubMed Web of Science ®Google Scholar
• Wertz DC, Sorenson JR, Heeren TC. Clients' interpretation of risks provided in genetic counseling. Am J Hum Genet 1986; 9: 253–64.
   Google Scholar
• Hallowell N, Murton F. The value of written summaries of genetic consultations. Patient Education and Counseling 1998; 35: 27–34.
   PubMedGoogle Scholar
• Genetic Testing Working Group of the NHMRC National Breast Care Centres. Current best advice about familial as-pects of breast cancer. Kings Cross: Australia, 1997.
   Google Scholar
• Report of consensus meeting on the management of women with a family history of breast cancer. Unit for Public Health Genetics, Cambridge, UK: 1998.
   Google Scholar
• Nuffield Council on Bioethics. Mental disorders and genetics: the ethical context. London: Nuffield Council on Bioethics, 1998.
   Google Scholar